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ABSTRACT 
 
UTILIZATION STUDY OF ANTIHYPERTENSIVE DRUGS IN 
PATIENTS WITH NEPHROPATHIC DIABETES (Study in 
Outpatient Installation in Airlangga University Hospital Surabaya) 
 
 
Venna Mayda Pratiwi 
 
Background : Nephropathic diabetes (ND) is a common complication of 
diabetesmellitus. Hypertension can increase the progressivity of 
nephropathy. Antihypertensif therapy is aimed to reduce the progression of 
the nephropathy disease and preventing more complications.  
Aim : the aim of this study is to analyze the utilization of antihypertensive 
drugsin nephropathic diabetes patients.  
Methods : It was an observational study with retrospective data collection 
basedon patients‟ medical records in Outpatients Instalation in RSUA 
Surabaya from January 1, 2018-March 31, 2018.  
Results : There were 46 patients who met the inclusion criteria. Based on 
GFRscore, the most common classification of renal impairment in patients 
with diabetes in this study was on stage 4 (30.43%). The most common 
complications were hypertension (52.17%) and hiperlipidemia (21.74%). The 
drugs that often used were ARB (27.71%), CCB 27.07%, β-blockers 18.79%, 
diuretics loop (12.42%), ACE-I (7.96%), and potassium-sparing diuretics 
(6.05%). In this study, single antihypertensive use was 30.43%, two 
combinations antihypertensives were 31.84%, combinations three were 
25.33%, combinations four were 11.57%, and combinations five were 1.44%. 
Drug related problem of potential drug interaction is candesartan & 
spironolacton 2.90%, ACE-I & ARB 2.17%. The average of blood pressure 
measurement that achieved therapy goal (<140/90mmHg) is 30.2%. 
 
 
Keywords : drug utilization study, nephropathic diabetes, antihypertensive 
drugs. 
  
I R - PERPUSTAKAAN UNIVERSITAS AIRLANGGA 
SKRIPSI STUDI PENGGUNAAN ANTIHIPERTENSI... VENNA MAYDA PRATIWI
